CSI Market
Sign In | Register

Infinity Pharmaceuticals Inc (INFI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access INFI Annual Cash Flow →
From Infinity Pharmaceuticals Inc through Jun 30 2022, changes in Jun 30 2023's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2023)
6 Months 		(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Operating Activities
Income-9.96
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.86
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Marketable Securities Realized Gain Loss-
Amortization Of Loan Commitment Asset-
Impairment Of Investments-
Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities-2.23
Noncash Interest Expense On Long Term Debt Due To Related Party-
Gain From Written Notice of Termination-
Noncash Royalty Revenue-0.39
Noncash Interest Expense-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Receivables0.00
Increase (Decrease) in Notes Payable, Current0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities9.10
Discontinued operations0.00
Net Cash flow from Operating Activities0.00
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities0.00
Payments to Acquire Available-for-sale Securities, Debt0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Long Term Debt From Related Party-
Proceeds From Issuance Of Common Stock To Related Entities-
Release Of Restricted Cash-
Proceeds From Issuance Of Common Stock To Related Party-
Payments On Construction Liability-
Payments Of Financing Obligation-
Proceeds From Sale Of Future Royalties Net-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents38.47
Proceeds From Sale Of Future Royalties Related Party Net-
Proceeds From Issuance Of Common Stock Under Sales Facility-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow0.00
Total Cash Flow0.00
4 historic quarters locked

Sign in to unlock the full Infinity Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Infinity Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001113148-23-000009

Figures are derived from filed reports and may be restated. Historical data is subject to revision.